Healthcare Industry News: shoulder replacement
News Release - March 2, 2020
FX Solutions, SAS. [FX Shoulder, Inc.] Receives FDA 510k Clearances for Glenoid Baseplate With a Central Screw and 32mm Glenosphere and Humeral CupsFDA Clearance Further Expands FX's Shoulder Arthroplasty Portfolio
DALLAS, March 2, 2020 -- (Healthcare Sales & Marketing Network) -- FX received 510k clearances for their Glenoid Baseplate with a Central Screw and 32mm Glenosphere and Humeral Cups for reverse shoulder arthroplasty.
The 32mm Glenosphere and Humeral Cups further expand the offerings that FX has available to the US market, which includes the existing sizes of 36mm and 40mm. With the 32mm components added to the FX portfolio, surgeons may be able to address more diverse patient needs.
"These are significant achievements and additions for our portfolio. There is a constant need and request for exactly these types of implants. They complement what we already have and, even more so, allows us to further compete in an extremely competitive market," said Baptiste Martin, CEO of FX Shoulder USA. "These additions continue our adventure…" he continued to say.
To see the entire FX portfolio, please visit our exhibit booth at AAOS in Orlando from March 25-27, 2020.
FX Shoulder USA, Inc. is based in Dallas, TX and is the direct provider of FX Solutions shoulder replacement devices in the U.S. FX Shoulder USA, Inc., founded in January 2018, focuses exclusively on shoulder arthroplasty. For additional information, please visit www.fxshoulder.com.
Source: FX Solutions
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.